WHITNEY RIVKIN: Open Payments
NPI 1609128628 · CHAMBLEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 18 payments from 9 companies in 2025. Trend: 2023 $978 · 2024 $579 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| ViiV Healthcare Company | 1 | $93 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Abbott Laboratories | 1 | $27 |
| PFIZER INC. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $13 |
Products named: LEQVIO, LifeVest, JARDIANCE, CARDIOMEMS, VYNDAQEL, ENTRESTO, Kerendia, REPATHA.
Industry payments across GA — which companies pay providers there.
